연구성과로 돌아가기
2023 연구자 정보 (33 / 1135)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Yan, Z. (Yan, Z) |
Tianjin Med Univ, Canc Inst & Hosp, Dept Integrat Oncol, Tianjin, Peoples R China |
|
|
[JCR상위 1.1] Bemarituzumab (bema)+FOLFOX6 as first-line treatment in patients with FGFR2b overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer (G/ GEJC): East Asia subgroup of FIGHT final analysis | SCIE | 1.1 | ONCOLOGY | |||
|
Yau, T. (Yau, T) |
Univ Hong Kong, Med Dept, Queen Mary Hosp, Pokfulam, Hong Kong, Peoples R China |
B-3429-2011 Yau, Thomas |
|
[JCR상위 1.1] Pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) compared with gem/cis alone for patients (pts) with advanced biliary tract cancer (BTC): Updated efficacy and safety from KEYNOTE-966 | SCIE | 1.1 | ONCOLOGY | |||
|
Yerushalmi, R. (Yerushalmi, R) |
Tel Aviv Univ, Inst Oncol, Davidoff Ctr, Rabin Med Ctr, Petah Tiqwa, Israel |
|
|
[JCR상위 1.1] Subgroup analysis of patients (pts) with HER2-low metastatic breast cancer (mBC) with brain metastases (BMs) at baseline from DESTINY-Breast04, a randomized phase III study of trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC) | SCIE | 1.1 | ONCOLOGY | |||
|
Yoo, C. (Yoo, C) |
Univ Ulsan, Dept Oncol, Asan Med Ctr, Coll Med, Seoul, South Korea Kyung Hee Univ, Dept Phys, 26 Kyungheedae Ro, Seoul 02447, South Korea |
|
|
[JCR상위 1.1] Pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) compared with gem/cis alone for patients (pts) with advanced biliary tract cancer (BTC): Updated efficacy and safety from KEYNOTE-966 [JCR상위 74.3] The acrylic vessel for JSNS²-II neutrino target |
SCIE | 1.1 |
ONCOLOGY INSTRUMENTS & INSTRUMENTATION |
takasumi.maruyama@kek.jp; | ||
|
Yoon, J-K. (Yoon, JK) |
Stanford Univ, Div Pulmonol Allergy & Crit Care, Dept Med, Sch Med, Stanford, CA USA |
|
|
[JCR상위 1.1] Enhancing lung nodule discrimination with a novel cfDNA test: The cancer signature ensemble (CSE) approach | SCIE | 1.1 | ONCOLOGY | |||
|
Yu, L. (Yu, L) |
Merck & Co Inc, Oncol, Riverside, CA USA |
|
|
[JCR상위 1.1] Pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) compared with gem/cis alone for patients (pts) with advanced biliary tract cancer (BTC): Updated efficacy and safety from KEYNOTE-966 | SCIE | 1.1 | ONCOLOGY | |||
|
Yung, L. (Yung, L) |
Daiichi Sankyo Inc, Global Oncol R&D, Basking Ridge, NJ USA |
|
|
[JCR상위 1.1] Subgroup analysis of patients (pts) with HER2-low metastatic breast cancer (mBC) with brain metastases (BMs) at baseline from DESTINY-Breast04, a randomized phase III study of trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC) | SCIE | 1.1 | ONCOLOGY | |||
|
Yusuf, A. (Yusuf, A) |
Amgen Headquarters USA, Global Med Org, Thousand Oaks, CA USA |
|
|
[JCR상위 1.1] Bemarituzumab (bema)+FOLFOX6 as first-line treatment in patients with FGFR2b overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer (G/ GEJC): East Asia subgroup of FIGHT final analysis | SCIE | 1.1 | ONCOLOGY | |||
|
Zada, Amir (Zada, A) |
Abdul Wali Khan Univ Mardan, Dept Chem, Khyber Pakhtunkhwa 23200, Pakistan |
GVT-1988-2022 Zada, Amir |
|
[JCR상위 1.1] Exploration of metal organic frameworks and covalent organic frameworks for energy-related applications | SCIE | 1.1 | CHEMISTRY, INORGANIC & NUCLEAR | Jiabao.yi@newcastle.edu.au;liang.qiao@uestc.edu.cn; | ||
|
Zahlten-Kuemeli, A. (Zahlten-Kuemeli, A) |
Amgen Inc SSF, Oncol Dept, San Francisco, CA USA |
|
|
[JCR상위 1.1] Bemarituzumab (bema)+FOLFOX6 as first-line treatment in patients with FGFR2b overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer (G/ GEJC): East Asia subgroup of FIGHT final analysis | SCIE | 1.1 | ONCOLOGY | |||
|
Zu, Xiaotao (Zu, XT) |
Univ Elect Sci & Technol China, Sch Phys, Chengdu 610054, Peoples R China |
|
|
[JCR상위 1.1] Exploration of metal organic frameworks and covalent organic frameworks for energy-related applications | SCIE | 1.1 | CHEMISTRY, INORGANIC & NUCLEAR | Jiabao.yi@newcastle.edu.au;liang.qiao@uestc.edu.cn; | ||
|
Bae, Su Jin (Bae, SJ) |
Dongguk Univ, Sch Korean Med, Gyeongju, South Korea |
|
0000-0001-8884-7940 Bae, Su-jin |
[JCR상위 1.2] Systemic and molecular analysis dissect the red ginseng induction of apoptosis and autophagy in HCC as mediated with AMPK | SCIE | 1.2 | CHEMISTRY, MEDICINAL;INTEGRATIVE & COMPLEMENTARY MEDICINE | sckim@dhu.ac.kr;yun2546@gmail.com;kipark@gnu.ac.kr; | ||
|
Baek, Seunghwi (Baek, S) |
제1저자 | Pusan Natl Univ, Sch Mech Engn, Busan, South Korea |
|
|
[JCR상위 1.2] Recent Progress of Potassium Metal Anodes: How to Regulate the Growth of Dendrite | SCIE | 1.2 | ENERGY & FUELS;NUCLEAR SCIENCE & TECHNOLOGY | sunghwi97@pusan.ac.kr;jts5333@pusan.ac.kr;jsh981021@pusan.ac.kr;myeongjinkim@knu.ac.kr;blee1015@pusan.ac.kr; | |
|
Bang, S. (Bang, S) |
Yonsei Univ, Dept Urol Urol Sci Inst, Severance Hosp, Coll Med, Seoul, South Korea |
|
|
[JCR상위 1.2] Predictive model for one-session success rate of shock wave lithotripsy using linear calculus density | SCIE | 1.2 | UROLOGY & NEPHROLOGY | |||
|
Cho, Han -Sung (Cho, HS) |
Konkuk Univ, Coll Vet Med, Dept Physiol, Ginsentol Res Lab, Seoul, South Korea |
|
|
[JCR상위 1.2] A novel protocol for batch-separating gintonin-enriched, polysaccharide-enriched, and crude ginsenoside-containing fractions from Panax ginseng | SCIE | 1.2 | CHEMISTRY, MEDICINAL;INTEGRATIVE & COMPLEMENTARY MEDICINE | rmlee12@konkuk.ac.kr;newlove0202@nate.com;bioskjh@naver.com;ouddi80@naver.com;vettman@naver.com;sunghhwang@sangji.ac.kr;hrhim@kist.re.kr;ihcho@khu.ac.kr;rheemh@knu.ac.kr;kimvet0911@kbri.re.kr;kimhc@kangwon.ac.kr;synah@konkuk.ac.kr; |
페이지 이동: